291 related articles for article (PubMed ID: 17379313)
1. Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo.
Buenz EJ; Howe CL
Neurotoxicology; 2007 May; 28(3):702-4. PubMed ID: 17379313
[TBL] [Abstract][Full Text] [Related]
2. beta-N-methylamino-L-alanine induced in vivo retinal cell death.
Santucci S; Zsürger N; Chabry J
J Neurochem; 2009 May; 109(3):819-25. PubMed ID: 19309437
[TBL] [Abstract][Full Text] [Related]
3. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
Rao SD; Banack SA; Cox PA; Weiss JH
Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
[TBL] [Abstract][Full Text] [Related]
4. Animal models of BMAA neurotoxicity: a critical review.
Karamyan VT; Speth RC
Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
[TBL] [Abstract][Full Text] [Related]
5. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
Liu X; Rush T; Zapata J; Lobner D
Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
7. Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice.
Cruz-Aguado R; Winkler D; Shaw CA
Pharmacol Biochem Behav; 2006 Jun; 84(2):294-9. PubMed ID: 16808967
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
[TBL] [Abstract][Full Text] [Related]
9. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
10. Weak BMAA toxicity compares with that of the dietary supplement β-alanine.
Lee M; McGeer PL
Neurobiol Aging; 2012 Jul; 33(7):1440-7. PubMed ID: 21236519
[TBL] [Abstract][Full Text] [Related]
11. Early hippocampal cell death, and late learning and memory deficits in rats exposed to the environmental toxin BMAA (β-N-methylamino-L-alanine) during the neonatal period.
Karlsson O; Roman E; Berg AL; Brittebo EB
Behav Brain Res; 2011 Jun; 219(2):310-20. PubMed ID: 21315110
[TBL] [Abstract][Full Text] [Related]
12. Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy.
Karlsson O; Berg C; Brittebo EB; Lindquist NG
Pigment Cell Melanoma Res; 2009 Feb; 22(1):120-30. PubMed ID: 19154235
[TBL] [Abstract][Full Text] [Related]
13. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
14. Augmentation and ionic mechanism of effect of beta-N-methylamino-L-alanine in presence of bicarbonate on membrane potential of Retzius nerve cells of the leech Haemopis sanguisuga.
Lopicic S; Nedeljkov V; Cemerikic D
Comp Biochem Physiol A Mol Integr Physiol; 2009 Jul; 153(3):284-92. PubMed ID: 19272457
[TBL] [Abstract][Full Text] [Related]
15. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Ince PG; Codd GA
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
[TBL] [Abstract][Full Text] [Related]
16. The cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) induces neuronal and behavioral changes in honeybees.
Okle O; Rath L; Galizia CG; Dietrich DR
Toxicol Appl Pharmacol; 2013 Jul; 270(1):9-15. PubMed ID: 23591064
[TBL] [Abstract][Full Text] [Related]
17. BMAA--an unusual cyanobacterial neurotoxin.
Vyas KJ; Weiss JH
Amyotroph Lateral Scler; 2009; 10 Suppl 2():50-5. PubMed ID: 19929732
[TBL] [Abstract][Full Text] [Related]
18. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
Cox PA; Banack SA; Murch SJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
[TBL] [Abstract][Full Text] [Related]
19. An explanation for the changes in collagen in sporadic amyotrophic lateral sclerosis.
Field NC; Caller TA; Stommel EW
Med Hypotheses; 2011 Oct; 77(4):565-7. PubMed ID: 21745715
[TBL] [Abstract][Full Text] [Related]
20. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
